Metastatic Microsatellite Stable Colorectal Carcinoma Clinical Trials

13 clinical trials for Metastatic Microsatellite Stable Colorectal Carcinoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer — RECRUITING · PHASE1
• Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness — RECRUITING · PHASE1
• Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC — RECRUITING · PHASE1
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer — NOT_YET_RECRUITING · PHASE1
• Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) — WITHDRAWN · PHASE2
• Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer — COMPLETED · PHASE2
• A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer — TERMINATED · PHASE1
• Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer — WITHDRAWN · PHASE1

Refine this search